American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra.
Division of Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospitals and Clinics, Kansas City, MO 64108, USA.
Alan S
AS
Hollister
Gregory L
GL
Kearns
D001067:Appetite Depressants / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology; D004348:Drug Labeling; D029789:Ephedra / Q000009:adverse effects*; D004809:Ephedrine / Q000009:adverse effects*; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced / Q000453:epidemiology; D004366:Nonprescription Drugs; D010601:Pharmacology, Clinical; D012958:Societies, Scientific; D014481:United States / Q000453:epidemiology
D001067:Appetite Depressants; D004366:Nonprescription Drugs; D004809:Ephedrine